WALTHAM, Mass., April 02, 2024 Today, Revvity, Inc. (NYSE: RVTY) announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group (CSG) to comply with its contractual obligations under its strategic partner agreements with Revvity, including an order to cease all marketing, selling and support activities in Revvity’s exclusive markets and to continue delivering maintenance services to Revvity in relation to its Spotfire® software.
Today, Revvity, Inc. announced that the Massachusetts Superior Court has granted a preliminary injunction compelling Cloud Software Group to comply with its contractual obligations under its.
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical™ solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.
- Centralized data science platform streamlines clinical study data management for swift, insight-driven clinical decisions and therapeutic advancements- Seamless integration with Spotfire® for powerful visual analytics enabling flexibility, easy customization and scalability- Fosters cross-functional collaboration.
Signals Research Suite integrates workflows across biology, chemistry and materials new product development to arm scientists with better data, insights and outcomes
Centrally installed and. | June 12, 2023